Pueraria lobata for Diabetes Mellitus: Past, Present and Future
Pueraria lobata for Diabetes Mellitus: Past, Present and Future
Yang et al., 2019 | Am J Chin Med | Meta Analysis
Citation
Yang Lihong, Chen Jing, ... Guo Xinfeng. Pueraria lobata for Diabetes Mellitus: Past, Present and Future. Am J Chin Med. 2019;47(7):1419-1444. doi:10.1142/S0192415X19500733
Abstract
Gegen (Radix Puerariae Lobatae), the root of Pueraria lobata, is an edible and medicinal herb which has been used in treating diabetic symptoms in the orient for thousands of years. We present an evidence map of the efficacy and safety of Gegen and Gegen formulas (GGFs) that use Gegen as an essential herb for diabetes, and also its mechanism of actions. We comprehensively searched the ancient medical records to identify empirical evidence; conducted a systematic review (SR) based on moderate- to high-quality randomized controlled trials (RCTs) to synthesize the clinical evidence; and reviewed the possible mechanisms of its antidiabetic effects. Empirical application of Gegen in treating diabetic symptoms dated back to more than 2000 years ago. Common herbs used in RCTs that accompany with Gegen included Radix et Rhizoma Glycyrrhizae, Radix et Rhizoma Ginseng, Rhizoma Dioscoreae, Poria, and Radix Ophiopogonis. The combinations used today are consistent with their usage in ancient times. Results of the SR showed that GGFs could benefit patients with type 2 diabetes for blood glucose control. When in combination with hypoglycemic agents or insulin, GGFs enhanced the glucose-lowering effect as well as the lipid-lowering effects. Also, the incidence and the risk of adverse events (AE), especially the hypoglycemic episodes, were lower in the combination group. No serious or life-threatening AE was reported. The experimental evidence presented that Gegen and GGFs might exert and enhance the anti-diabetic effects through activation of multiple mechanisms, such as reducing insulin resistance, increasing insulin release, inhibiting glucose absorption and reabsorption, and improving insulin sensitivity, glucose uptake, and metabolism.
Key Findings
The experimental evidence presented that Gegen and GGFs might exert and enhance the anti-diabetic effects through activation of multiple mechanisms, such as reducing insulin resistance, increasing insulin release, inhibiting glucose absorption and reabsorption, and improving insulin sensitivity, glucose uptake, and metabolism.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | type 2 diabetes for |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | diabetes |
MeSH Terms
- China
- Diabetes Mellitus, Type 2
- Drugs, Chinese Herbal
- History, 21st Century
- History, Ancient
- Humans
- Hypoglycemic Agents
- Medicine in Literature
- Pueraria
- Randomized Controlled Trials as Topic
- Rhizome
Evidence Classification
- Level: Meta Analysis
- Publication Types: Historical Article, Journal Article, Meta-Analysis, Systematic Review
- Vertical: ginseng
Provenance
- PMID: 31659910
- DOI: 10.1142/S0192415X19500733
- PMCID: Not in PMC
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09